HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiepileptic drugs are not independently associated with cognitive dysfunction.

AbstractOBJECTIVE:
To test the hypothesis that individual antiepileptic drugs (AEDs) are not associated with cognitive impairment beyond other clinically relevant factors, we performed a cross-sectional study of patients admitted to an inpatient video-EEG monitoring unit.
METHODS:
We prospectively enrolled patients admitted to an inpatient specialist epilepsy program between 2009 and 2016. Assessments included objective cognitive function, quality of life subscales for subjective cognitive function, and questionnaires for anxiety and depressive symptoms. Bayesian model averaging identified predictors of cognitive function. Bayesian model selection approach investigated effect of individual AEDs on cognition. Conventional frequentist analyses were also performed.
RESULTS:
A total of 331 patients met inclusion criteria. Mean age was 39.3 years and 61.9% of patients were women. A total of 45.0% of patients were prescribed AED polypharmacy, 25.1% AED monotherapy, and 29.9% no AED. Age, seizure frequency, and a diagnosis of concomitant epilepsy and psychogenic nonepileptic seizure were predictors of objective cognitive function. Depression, anxiety, and seizure frequency were predictors of subjective cognitive function. Individual AEDs were not independently associated with impaired cognitive function beyond other clinically relevant variables.
CONCLUSIONS:
This study found that no AED was independently associated with cognitive dysfunction. Significant determinants of objective and subjective cognitive dysfunction included seizure frequency and depression, respectively. These findings suggest that optimizing therapy to prevent seizures is not likely to occur at the expense of cognitive function.
AuthorsEmma Foster, Charles B Malpas, Karena Ye, Benjamin Johnstone, Patrick W Carney, Dennis Velakoulis, Terence J O'Brien, Patrick Kwan
JournalNeurology (Neurology) Vol. 94 Issue 10 Pg. e1051-e1061 (03 10 2020) ISSN: 1526-632X [Electronic] United States
PMID32015172 (Publication Type: Journal Article)
Copyright© 2020 American Academy of Neurology.
Chemical References
  • Anticonvulsants
Topics
  • Adolescent
  • Adult
  • Aged
  • Anticonvulsants (adverse effects)
  • Cognitive Dysfunction (chemically induced, physiopathology)
  • Cross-Sectional Studies
  • Depression (physiopathology)
  • Drug Therapy, Combination
  • Epilepsy (drug therapy, physiopathology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polypharmacy
  • Quality Assurance, Health Care
  • Quality of Life
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: